000952.SZ · 广济药业
China A-shares · RS rating 82 · As of 2026-10-14
| Price | 6.45 CNY |
|---|---|
| 1-day change | -2.1% |
| RS rating (overall / 1M / 3M / 12M) | 82 / 61 / 88 / 73 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 23 / 15 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -8.7% |
| Distance from 52-week high | +38.1% |
| Market cap (USD) | $344.2M |